Page last updated: 2024-12-07

n-tert-butyl-alpha-(4-nitrophenyl)nitrone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-tert-butyl-alpha-(4-nitrophenyl)nitrone: RN given from Aldrich 1990-1991 catalog [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3035370
CHEMBL ID240122
MeSH IDM0191549

Synonyms (7)

Synonym
n-tert-butyl-.alpha.-(4-nitrophenyl)nitrone
n-tert-butyl-alpha-(4-nitrophenyl)nitrone
n-tert-pbn
CHEMBL240122
n-tert-butyl-1-(4-nitrophenyl)methanimine oxide
nsc 376702
2-propanamine, 2-methyl-n-((4-nitrophenyl)methylene)-, n-oxide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID307144Protective effect against ischemia/reperfusion-induced microvascular damages in golden hamster assessed as number of leakage site per cm^2 at 3 mg/kg, po after 10 mins by cheek pouch assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Alpha-phenyl-N-tert-butyl nitrone (PBN) derivatives: synthesis and protective action against microvascular damages induced by ischemia/reperfusion.
AID307145Protective effect against ischemia/reperfusion-induced microvascular damages in golden hamster assessed as number of leakage site per cm^2 at 3 mg/kg, po after 15 mins by cheek pouch assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Alpha-phenyl-N-tert-butyl nitrone (PBN) derivatives: synthesis and protective action against microvascular damages induced by ischemia/reperfusion.
AID307148Partition coefficient, log P of the compound2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Alpha-phenyl-N-tert-butyl nitrone (PBN) derivatives: synthesis and protective action against microvascular damages induced by ischemia/reperfusion.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]